Filing Details
- Accession Number:
- 0001209191-23-054355
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-03 16:55:17
- Reporting Period:
- 2023-11-01
- Accepted Time:
- 2023-11-03 16:55:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1783183 | Phathom Pharmaceuticals Inc. | PHAT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363812 | Molly Henderson | C/O Phathom Pharmaceuticals, Inc. 100 Campus Drive, Suite 102 Florham NJ 07932 | Cfo And Cbo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-01 | 22,500 | $0.00 | 117,680 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-11-01 | 811 | $7.80 | 116,869 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-11-01 | 11,681 | $8.95 | 105,188 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,134 | Indirect | By 401(k) |
Footnotes
- Represents shares earned with respect to a performance stock unit award granted on January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023.
- Represents shares sold to satisfy tax withholding obligations upon the settlement of performance stock units.
Billionaire Hedge Funds
